Literature DB >> 8490472

Rationale for stopping cervical screening in women over 50.

W J Van Wijngaarden1, I D Duncan.   

Abstract

OBJECTIVE: To investigate whether the currently recommended age at which to stop cervical screening (64) can be lowered and what criteria should be used for safely doing so.
DESIGN: Retrospective case analysis study.
SETTING: Dundee and Angus districts of Scotland.
SUBJECTS: Women diagnosed as having cervical intraepithelial neoplasia and microinvasive or invasive cancer of the cervix in 1989 and 1990 (798 cases). MAIN OUTCOME MEASURE: History of cervical cytology results according to age (age groups of five years) and screening interval (three years and five years).
RESULTS: Cervical intraepithelial neoplasia was most common in women under 45 (711 cases in women of 45 and under v 38 cases in those of 46 and over). Cervical intraepithelial neoplasia occurring de novo was not seen in women over 50 who had been screened every three years. Microinvasive or invasive cancer of the cervix was diagnosed in 26 women over 50. None of these women had participated adequately in the cervical screening programme.
CONCLUSION: Cervical intraepithelial neoplasia typically occurs in younger women. All women over 50 with an adequate history of negative results on smear testing every three years may be safely discharged from further screening if these findings are confirmed in other populations.

Entities:  

Mesh:

Year:  1993        PMID: 8490472      PMCID: PMC1677423          DOI: 10.1136/bmj.306.6883.967

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  2 in total

Review 1.  Screening for cancer of the cervix in elderly women.

Authors:  A Fletcher
Journal:  Lancet       Date:  1990-01-13       Impact factor: 79.321

2.  Screening for cervical intraepithelial neoplasia in Dundee and Angus 1962-81 and its relation with invasive cervical cancer.

Authors:  H L Duguid; I D Duncan; J Currie
Journal:  Lancet       Date:  1985-11-09       Impact factor: 79.321

  2 in total
  18 in total

Review 1.  How can we develop a cost-effective quality cervical screening programme?

Authors:  Sue Wilson; Helen Lester
Journal:  Br J Gen Pract       Date:  2002-06       Impact factor: 5.386

Review 2.  Cervical cancer: developments in screening and evaluation of the abnormal Pap smear.

Authors:  J M Walsh
Journal:  West J Med       Date:  1998-11

3.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study.

Authors:  C Sherlaw-Johnson; S Gallivan; D Jenkins
Journal:  BMJ       Date:  1999-02-06

Review 4.  [Pro: a critical contribution to better understanding of possible functional disorders of the genital, bladder and pelvic floor system].

Authors:  B Schüssler
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

5.  Upper age limit for cervical screening.

Authors:  W J van Wijngaarden; I D Duncan
Journal:  BMJ       Date:  1993-05-22

6.  Cervical screening in women over 50.

Authors:  R P Symonds; D W Lamont
Journal:  BMJ       Date:  1993-06-12

7.  Prospective evaluation of a risk scoring system for cervical neoplasia in primary care.

Authors:  C E Wilkinson; T J Peters; N C Stott; I M Harvey
Journal:  Br J Gen Pract       Date:  1994-08       Impact factor: 5.386

8.  Cluster-randomised trial of risk communication to enhance informed uptake of cervical screening.

Authors:  Rachel M Holloway; Clare Wilkinson; Tim J Peters; Ian Russell; David Cohen; Janine Hale; Cerilan Rogers; Helen Lewis
Journal:  Br J Gen Pract       Date:  2003-08       Impact factor: 5.386

9.  Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease.

Authors:  J E Macgregor; M K Campbell; E M Mann; K Y Swanson
Journal:  BMJ       Date:  1994-05-28

10.  Incidence of cervical cancer after several negative smear results by age 50: prospective observational study.

Authors:  Matejka Rebolj; Marjolein van Ballegooijen; Elsebeth Lynge; Caspar Looman; Marie-Louise Essink-Bot; Rob Boer; Dik Habbema
Journal:  BMJ       Date:  2009-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.